
Keywords: cardiac allograft vasculopathy; heart transplantation; immunosuppression; stem cells; tissue engineering; transplant rejection; ACR; acute cellular rejection; AMR; antibody-mediated rejection; CMR; cardiac magnetic resonance; CNI; calcineurin inhibitor; C